COVID-19 Impact on Clinical Chemistry Analyzer in Healthcare Industry
As well as the global economic environment, the COVID-19 pandemic has had an unforeseen effect on everyday life. The effect on the healthcare industry has also been dramatically changed and a huge pressure is being generated on healthcare services that are already stretched across the globe.
Emerging literature on COVID-19 shows that both in the general population and within high-risk populations, the Coronavirus pandemic has intensified psychological distress. Till July 2020, it became obvious that the novel strain of Coronavirus or COVID-19 has major impact on the healthcare system in the United States.
PRICE IMPACT
The COVID-19 had a devastating impact on the global economy. As they attempted to survive the extraordinary turmoil, the few businesses must stay closed while others must scale down the activities or placed on hold expansion plans. Clinical chemistry analyzers are devices that carry out assays on clinical samples, such as plasma, urine, blood, serum and cerebrospinal fluid to determine the presence of analyzers relating to drugs and diseases.
Despite the current crisis healthcare issue in the country continues to reel under the positive impact of COVID-19 on the market of clinical chemical analyzers due to its use in detection of samples of COVID-19. Since the cases of COVID-19 are increasing day by day so is the testing demand is increasing which therefore increases the prices of tests that are performed in laboratories.
But as the demand increases the competition between different manufactures is increasing for manufacturing novel clinical analyzers for the tests.
IMPACT ON DEMAND
The demand for clinical chemistry analyzers is increasing even in this pandemic because, of its regular use and others benefits that comes with the installation of these analyzers in the laboratory. Continue..